This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Track changes in personal budgets to understand drivers, uncover trends, and refine spending and saving habits.
22,888 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
As AI-driven gains fade in 2026, investors face a choice on covered call ETFs. This piece breaks down performance, ri...
When headlines warn of a strike and then show diplomacy's glow, oil markets react in real time. This guide outlines s...
Micron just beat earnings, but the stock didn’t soar. This article breaks down what happened, how AI demand, margins,...
Brokerages launch pilots that allow 13-year-olds to trade stocks with limited parental approval, prompting wide-rangi...
A top dividend-focused ETF is delivering gains, but I refuse to stop buying. Here’s how the approach stays discipline...
A new analyst survey shows overwhelming Buy ratings for Amazon, with no Sell calls. The result comes as AWS accelerat...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
TON surged in a bold governance shift as Telegram announced it would assume the network’s governance role and validat...
A Bitcoin wallet idle since 2013 sent 500 BTC, valued around $40 million, to a new address on May 11, 2026. The move ...